JSM 2005 - Toronto

JSM Activity #120

This is the preliminary program for the 2005 Joint Statistical Meetings in Minneapolis, Minnesota. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2005); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.



The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

The Program has labeled the meeting rooms with "letters" preceding the name of the room, designating in which facility the room is located:

Minneapolis Convention Center = “MCC” Hilton Minneapolis Hotel = “H” Hyatt Regency Minneapolis = “HY”

Back to main JSM 2005 Program page
Legend: = Applied Session, = Theme Session, = Presenter
Add To My Program
120 Applied Session Mon, 8/8/05, 10:30 AM - 12:20 PM MCC-102 C
Importance of "P-values" in Drug Approval Process - Pros and Cons - Invited - Papers
Biopharmaceutical Section, Section on Statistical Education, WNAR
Organizer(s): Ramachandran Suresh, Schering-Plough
Chair(s): Ramachandran Suresh, Schering-Plough
     10:35 AM   What Would Fisher or Neyman Say? — David Salsburg, Statistical Consultant
     11:00 AM   Assess the Strength of Statistical Evidence, Not the P-value — Jeffrey D. Blume, Brown University
     11:25 AM   Can We Do More Than P-values in Drug Evaluation? — Lee-Jen Wei, Harvard University
     11:50 AM   Disc: Robert O'Neill, U.S. Food and Drug Administration
     12:10 PM   Floor Discussion
 

JSM 2005 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2005